anti-CD137L (human), mAb (41B436)

AdipoGen Life Sciences

anti-CD137L (human), mAb (41B436)

10

Flow Cytometry, Western Blot, ELISA, ImmunoCytoChemistry

Research Use Only

Monoclonal

41B436

1 mg/ml

TNFSF9

TNF superfamily member 9

4-1BB-L, CD137L, TNLG5A, tumor necrosis factor ligand superfamily member 9, 4-1BB ligand, 4-1BBL, CD137 ligand, homolog of mouse 4-1BB-L, receptor 4-1BB ligand, tumor necrosis factor (ligand) superfamily, member 9, tumor necrosis factor ligand 5A, tumor necrosis factor superfamily member 9

Mouse

IgG1

Tumor necrosis factor ligand superfamily member 9

Monoclonal Antibody. Recognizes extracellular domain of human CD137L. Does not cross-react with mouse CD137L. Isotype: Mouse IgG1kappa. Clone: 41B436. Applications: ELISA, FACS, ICC, WB. Liquid. 0.2microm-filtered solution in PBS, pH 7.4. Contains no preservatives. The CD137 ligand (CD137L, 4-1BBL) is a member of the tumor necrosis factor (TNF) family. CD137L is a type II, transmembrane protein found on activated macrophages, dendritic cells and mature B cells. The interaction with its receptor 4-1BB induces recruitment of TNF receptor-associated factor 1 (TRAF1) and TRAF2 and interaction with the kinase p56lck. CD137 and CD137L have been reported to be involved in tumor rejection, apoptosis, anti-viral immunity, diabetes, in T and B cell co-stimulation and modulation of the immune response. - The CD137 ligand (CD137L, 4-1BBL) is a member of the tumor necrosis factor (TNF) family. CD137L is a type II, transmembrane protein found on activated macrophages, dendritic cells and mature B cells. The interaction with its receptor 4-1BB induces recruitment of TNF receptor-associated factor 1 (TRAF1) and TRAF2 and interaction with the kinase p56lck. CD137 and CD137L have been reported to be involved in tumor rejection, apoptosis, anti-viral immunity, diabetes, in T and B cell co-stimulation and modulation of the immune response.

-20°C,2°C to 8°C

12352203